LT3607962T - Vien tik angiotenzinas ii arba derinyje, skirtas hipotenzijos gydymui - Google Patents

Vien tik angiotenzinas ii arba derinyje, skirtas hipotenzijos gydymui

Info

Publication number
LT3607962T
LT3607962T LTEP19197866.7T LT19197866T LT3607962T LT 3607962 T LT3607962 T LT 3607962T LT 19197866 T LT19197866 T LT 19197866T LT 3607962 T LT3607962 T LT 3607962T
Authority
LT
Lithuania
Prior art keywords
hypotension
angiotensin
solely
treatment
combination
Prior art date
Application number
LTEP19197866.7T
Other languages
English (en)
Lithuanian (lt)
Inventor
Lakhmir Chawla
Original Assignee
The George Washington University, A Congressionally Chartered Not-For-Profit Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53367119&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3607962(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The George Washington University, A Congressionally Chartered Not-For-Profit Corporation filed Critical The George Washington University, A Congressionally Chartered Not-For-Profit Corporation
Publication of LT3607962T publication Critical patent/LT3607962T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/085Angiotensins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTEP19197866.7T 2013-12-18 2014-12-18 Vien tik angiotenzinas ii arba derinyje, skirtas hipotenzijos gydymui LT3607962T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361917576P 2013-12-18 2013-12-18
US201461955706P 2014-03-19 2014-03-19

Publications (1)

Publication Number Publication Date
LT3607962T true LT3607962T (lt) 2026-01-12

Family

ID=53367119

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP19197866.7T LT3607962T (lt) 2013-12-18 2014-12-18 Vien tik angiotenzinas ii arba derinyje, skirtas hipotenzijos gydymui
LTEP14872684.7T LT2986308T (lt) 2013-12-18 2014-12-18 Angiotenzino ii derinys hipotenzijai gydyti

Family Applications After (1)

Application Number Title Priority Date Filing Date
LTEP14872684.7T LT2986308T (lt) 2013-12-18 2014-12-18 Angiotenzino ii derinys hipotenzijai gydyti

Country Status (25)

Country Link
US (7) US9220745B2 (enExample)
EP (2) EP2986308B1 (enExample)
JP (4) JP6824739B2 (enExample)
KR (4) KR102399383B1 (enExample)
CN (4) CN106061493A (enExample)
AU (3) AU2014364528C1 (enExample)
BR (1) BR112016013961A2 (enExample)
CA (1) CA2933601A1 (enExample)
CY (1) CY1122604T1 (enExample)
DK (2) DK3607962T3 (enExample)
EA (1) EA037823B1 (enExample)
ES (1) ES2771749T3 (enExample)
FI (1) FI3607962T3 (enExample)
HR (1) HRP20200009T1 (enExample)
HU (1) HUE047062T2 (enExample)
IL (1) IL246162B (enExample)
LT (2) LT3607962T (enExample)
MX (2) MX380968B (enExample)
NZ (1) NZ721089A (enExample)
PL (1) PL2986308T3 (enExample)
PT (2) PT3607962T (enExample)
RS (1) RS59804B1 (enExample)
SI (1) SI2986308T1 (enExample)
SM (2) SMT202000018T1 (enExample)
WO (1) WO2015095535A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
US9220745B2 (en) 2013-12-18 2015-12-29 The George Washington University, a Congressionally Not-for-Profit Corporation Angiotensin II alone or in combination for the treatment of hypotension
KR20170026486A (ko) * 2014-07-08 2017-03-08 라 졸라 파마슈티칼 컴파니 저혈압 치료 방법
US9919022B2 (en) 2015-03-20 2018-03-20 Arthur J. ATKINSON, JR. Use of angiotensin II (AII) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps
BR112018013847A2 (pt) 2016-01-07 2018-12-18 La Jolla Pharma Co métodos para administrar a angiotensina ii
WO2017120440A1 (en) * 2016-01-07 2017-07-13 La Jolla Pharmaceutical Company Methods of administering vasopressors
WO2018191678A1 (en) * 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
WO2019118874A1 (en) * 2017-12-15 2019-06-20 La Jolla Pharma, Llc Angiotensin compositions and methods related thereto
US20250366467A1 (en) * 2022-06-15 2025-12-04 Virginia Commonwealth University Methods for fluid resuscitation of an organ donor
WO2024129057A1 (en) * 2022-12-12 2024-06-20 Proletariat Therapeutics, Inc. Methods of treating cardiac injury

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181008B (en) 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
US5216025A (en) 1989-09-13 1993-06-01 Board Of Regents, The University Of Texas System Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
EP1401864A1 (en) 2001-06-04 2004-03-31 Human Genome Sciences Methods and compositions for modulating ace-2 activity
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
JP2007510643A (ja) 2003-11-06 2007-04-26 ジーイー・ヘルスケア・アクスイェ・セルスカプ 医薬化合物
NO20034952D0 (no) 2003-11-06 2003-11-06 Amersham Health As Farmasöytiske forbindelser
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
DE602006021600D1 (de) 2005-09-29 2011-06-09 Fibrogen Inc Verfahren zur senkung des blutdrucks
AU2006332449B2 (en) 2005-12-30 2008-05-15 Howard Florey Institute Of Experimental Physiology And Medicine A method of treatment
WO2007146900A2 (en) 2006-06-15 2007-12-21 Gilead Colorado, Inc. Antihypertensive therapy method
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
CA2678131A1 (en) 2006-11-17 2008-05-22 Antoine Andremont Colonic delivery using zn/pectin beads with a eudragit coating.
WO2009009907A1 (en) * 2007-07-18 2009-01-22 The University Of British Columbia Use of vasopressin-receptor agonists for the treatment of septic shock
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
AU2009319856A1 (en) 2008-11-28 2010-06-03 Abbvie Inc. Stable antibody compositions and methods for stabilizing same
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
FR2959414B1 (fr) * 2010-04-30 2016-01-08 Luc Quintin Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire
BR112013000744A2 (pt) 2010-07-14 2020-07-14 Cumberland Emerging Technologies, Inc uso de um antagonista de receptor de tromboxana a2 para prevenção ou tratamento de síndrome hepatorrenal,encefalopatia hepática,e doenças associadas
AU2014256944B2 (en) 2013-04-26 2019-06-27 La Jolla Pharma, Llc Compositions and methods for treating renal failure
US9220745B2 (en) 2013-12-18 2015-12-29 The George Washington University, a Congressionally Not-for-Profit Corporation Angiotensin II alone or in combination for the treatment of hypotension
US20150286797A1 (en) 2014-04-02 2015-10-08 David R. Ratto System and method for administering medication
KR20170026486A (ko) 2014-07-08 2017-03-08 라 졸라 파마슈티칼 컴파니 저혈압 치료 방법
WO2017120440A1 (en) 2016-01-07 2017-07-13 La Jolla Pharmaceutical Company Methods of administering vasopressors
BR112018013847A2 (pt) 2016-01-07 2018-12-18 La Jolla Pharma Co métodos para administrar a angiotensina ii
WO2018191678A1 (en) 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
WO2019118874A1 (en) 2017-12-15 2019-06-20 La Jolla Pharma, Llc Angiotensin compositions and methods related thereto

Also Published As

Publication number Publication date
KR20220028125A (ko) 2022-03-08
KR20240154702A (ko) 2024-10-25
US11559559B2 (en) 2023-01-24
JP6824739B2 (ja) 2021-02-03
CA2933601A1 (en) 2015-06-25
DK2986308T3 (en) 2020-01-27
KR20160117437A (ko) 2016-10-10
US11096983B2 (en) 2021-08-24
AU2014364528A1 (en) 2016-06-30
US20180193407A1 (en) 2018-07-12
EP3607962B1 (en) 2025-08-13
MX380968B (es) 2025-03-12
AU2014364528C1 (en) 2021-01-07
NZ721089A (en) 2022-10-28
AU2014364528B2 (en) 2020-08-27
US9220745B2 (en) 2015-12-29
MX2020011190A (es) 2020-11-13
AU2020277230A1 (en) 2020-12-24
DK3607962T3 (da) 2025-11-17
US10493124B2 (en) 2019-12-03
WO2015095535A1 (en) 2015-06-25
FI3607962T3 (fi) 2025-11-24
RS59804B1 (sr) 2020-02-28
KR20230051721A (ko) 2023-04-18
JP2017501154A (ja) 2017-01-12
AU2024219851A1 (en) 2024-10-10
JP2019214610A (ja) 2019-12-19
KR102399383B1 (ko) 2022-05-19
CN119700926A (zh) 2025-03-28
HRP20200009T1 (hr) 2020-03-20
JP7175506B2 (ja) 2022-11-21
CN112546197A (zh) 2021-03-26
BR112016013961A2 (pt) 2017-10-10
AU2014364528A9 (en) 2016-07-28
EA037823B1 (ru) 2021-05-25
HUE047062T2 (hu) 2020-04-28
EP3607962A1 (en) 2020-02-12
SMT202000018T1 (it) 2020-03-13
JP2022137224A (ja) 2022-09-21
CN106061493A (zh) 2016-10-26
JP2025114753A (ja) 2025-08-05
US20190070250A1 (en) 2019-03-07
US20230226141A1 (en) 2023-07-20
LT2986308T (lt) 2020-03-25
PT2986308T (pt) 2020-01-21
US10765722B2 (en) 2020-09-08
CY1122604T1 (el) 2021-03-12
CN111920939A (zh) 2020-11-13
EP2986308B1 (en) 2019-10-16
EP2986308A1 (en) 2016-02-24
MX2016008108A (es) 2017-03-09
US10028995B2 (en) 2018-07-24
US20150164980A1 (en) 2015-06-18
US20220047669A1 (en) 2022-02-17
IL246162B (en) 2020-03-31
IL246162A0 (en) 2016-07-31
ES2771749T3 (es) 2020-07-07
SMT202500427T1 (it) 2026-01-12
US20160129072A1 (en) 2016-05-12
SI2986308T1 (sl) 2020-03-31
PT3607962T (pt) 2025-11-18
WO2015095535A9 (en) 2016-07-14
US20190328827A1 (en) 2019-10-31
EP2986308A4 (en) 2017-01-11
EA201691258A1 (ru) 2016-11-30
PL2986308T3 (pl) 2020-05-18

Similar Documents

Publication Publication Date Title
IL280908B (en) Combination therapy with neoantigen vaccine
LT3607962T (lt) Vien tik angiotenzinas ii arba derinyje, skirtas hipotenzijos gydymui
BR112016011572A2 (pt) grampo de oclusão
PL3542798T3 (pl) Aceklidyna do zastosowania w leczeniu starczowzroczności
BR112015007494A2 (pt) aparelho para tratamento dentário.
PL3301990T3 (pl) Sposób i przyrząd do ustanawiania powiązania
EP3057691A4 (en) PLASMA-TREATED POLYMER MEMBRANES
IL241461B (en) Methods for treating osteogenesis imperfecta
LT2945642T (lt) Faktoriaus 1 baltymas, skirtas naudoti ligų gydymui arba prevencijai
FI3753929T3 (fi) Dimeerisiä varjoaineita
DK2865469T4 (da) Spændeindretning
PL3236960T3 (pl) Fluralaner do zastosowania w leczeniu demodekozy
FR3007497B1 (fr) Verin roto-lineaire de bridage
DK2947323T3 (da) Spiralhuspumpe
EP3026106A4 (en) COMPOSITE STERILIZABLE BRACKET FOR ASEPTICAL TECHNICAL EXPERIMENTS
GB201305761D0 (en) Blood Pump
DK3071192T3 (da) Curcuphenolforbindelse til anvendelse i behandling af cancer
EP2986978A4 (en) MINIGELKAMM
DK2964248T3 (da) Behandling af og profylakse for stråledermatitis
GB201305758D0 (en) Blood Pump
PL3297622T3 (pl) Kombinacje oksykodonu i n-acyloetanoloaminy palmitoiloetanoloaminy do zmniejszenia skutków ubocznych związanych z opioidami
HUE051592T2 (hu) Kezelési módszer
FR3033251B1 (fr) Treuil d'evacuation en va-et-vient
DK3041506T3 (da) Behandlingsfremgangsmåde
IL240710A0 (en) Administration of sdf-1 to treat ischemic tissue